Ionis Pharmaceuticals

Ionis Pharmaceuticals

For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has five marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises.

Patient Support/Services, Pharmaceutical